<code id='58A3B6A640'></code><style id='58A3B6A640'></style>
    • <acronym id='58A3B6A640'></acronym>
      <center id='58A3B6A640'><center id='58A3B6A640'><tfoot id='58A3B6A640'></tfoot></center><abbr id='58A3B6A640'><dir id='58A3B6A640'><tfoot id='58A3B6A640'></tfoot><noframes id='58A3B6A640'>

    • <optgroup id='58A3B6A640'><strike id='58A3B6A640'><sup id='58A3B6A640'></sup></strike><code id='58A3B6A640'></code></optgroup>
        1. <b id='58A3B6A640'><label id='58A3B6A640'><select id='58A3B6A640'><dt id='58A3B6A640'><span id='58A3B6A640'></span></dt></select></label></b><u id='58A3B6A640'></u>
          <i id='58A3B6A640'><strike id='58A3B6A640'><tt id='58A3B6A640'><pre id='58A3B6A640'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:46
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.
          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

          AdobeDiagnosticerrors—thatis,overlookingadisease,ordiagnosingiterroneouslyorlate—areaknownoccurrence

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          New chief aims to remake Sanofi Genzyme

          NewSanofiGenzymepresidentBillSiboldisthefirstpersonwithoutanytiestoHenriTermeer(inset)toleadthecompa